Minal Barve
Sarah Cannon Research Institute(GB)Texas Oncology(US)Mary Crowley Cancer Research Center(US)Sarah Cannon(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers, Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials(2019)1,690 cited
- → Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C(2022)447 cited
- → Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study(2021)439 cited
- → SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study(2018)333 cited
- → First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1)(2022)291 cited
- → Adagrasib in Advanced Solid Tumors Harboring aKRASG12CMutation(2023)250 cited